Literature DB >> 10899173

The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways.

L H Xu1, X Yang, C A Bradham, D A Brenner, A S Baldwin, R J Craven, W G Cance.   

Abstract

The focal adhesion kinase (FAK) is a mediator of cell-extracellular matrix signaling events and is overexpressed in tumor cells. In order to rapidly down-regulate FAK function in normal and transformed mammary cells, we have used adenoviral gene transduction of the carboxyl-terminal domain of FAK (FAK-CD). Transduction of adenovirus containing FAK-CD in breast cancer cells caused loss of adhesion, degradation of p125(FAK), and induced apoptosis. Furthermore, breast tumor cells that were viable without matrix attachment also underwent apoptosis upon interruption of FAK function, demonstrating that FAK is a survival signal in breast tumor cells even in the absence of matrix signaling. In addition, both anchorage-dependent and anchorage-independent apoptotic signaling required Fas-associated death domain and caspase-8, suggesting that a death receptor-mediated apoptotic pathway is involved. Finally, FAK-CD had no effect on adhesion or viability in normal mammary cells, despite the loss of tyrosine phosphorylation of p125(FAK). These results indicate that FAK-mediated signaling is required for both cell adhesion and anchorage-independent survival and the disruption of FAK function involves the Fas-associated death domain and caspase-8 apoptotic pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899173     DOI: 10.1074/jbc.M910027199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  74 in total

1.  Proteolysis of the docking protein HEF1 and implications for focal adhesion dynamics.

Authors:  G M O'Neill; E A Golemis
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo.

Authors:  Vita M Golubovskaya; Sheila Figel; Baotran T Ho; Christopher P Johnson; Michael Yemma; Grace Huang; Min Zheng; Carl Nyberg; Andrew Magis; David A Ostrov; Irwin H Gelman; William G Cance
Journal:  Carcinogenesis       Date:  2012-03-07       Impact factor: 4.944

Review 3.  Integrin signaling and mammary cell function.

Authors:  Franziska Schatzmann; Rebecca Marlow; Charles H Streuli
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

4.  Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death.

Authors:  María José Hernández-Corbacho; Daniel Canals; Mohamad M Adada; Mengling Liu; Can E Senkal; Jae Kyo Yi; Cungui Mao; Chiara Luberto; Yusuf A Hannun; Lina M Obeid
Journal:  J Biol Chem       Date:  2015-08-28       Impact factor: 5.157

5.  Signaling pathway of globo-series glycosphingolipids and β1,3-galactosyltransferase V (β3GalT5) in breast cancer.

Authors:  Po-Kai Chuang; Michael Hsiao; Tsui-Ling Hsu; Chuan-Fa Chang; Chung-Yi Wu; Bo-Rui Chen; Han-Wen Huang; Kuo-Shiang Liao; Chen-Chun Chen; Chi-Long Chen; Shun-Min Yang; Chiung Wen Kuo; Peilin Chen; Ping-Tzu Chiu; I-Ju Chen; Jiann-Shiun Lai; Cheng-Der Tony Yu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-11       Impact factor: 11.205

6.  p53 regulates FAK expression in human tumor cells.

Authors:  Vita M Golubovskaya; Richard Finch; Frederick Kweh; Nicole A Massoll; Martha Campbell-Thompson; Margaret R Wallace; William G Cance
Journal:  Mol Carcinog       Date:  2008-05       Impact factor: 4.784

7.  Apoptosis of rat hepatic stellate cells induced by anti-focal adhesion kinase antibody.

Authors:  Xiao-Jing Liu; Li Yang; Hong-Bin Wu; Ou Qiang; Ming-Hui Huang; Ying-Ping Wang
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

Review 8.  Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics.

Authors:  William G Cance; Elena Kurenova; Timothy Marlowe; Vita Golubovskaya
Journal:  Sci Signal       Date:  2013-03-26       Impact factor: 8.192

9.  CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.

Authors:  Christophe Ginestier; Suling Liu; Mark E Diebel; Hasan Korkaya; Ming Luo; Marty Brown; Julien Wicinski; Olivier Cabaud; Emmanuelle Charafe-Jauffret; Daniel Birnbaum; Jun-Lin Guan; Gabriela Dontu; Max S Wicha
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

10.  Inhibition of the focal adhesion kinase and vascular endothelial growth factor receptor-3 interaction leads to decreased survival in human neuroblastoma cell lines.

Authors:  Elizabeth A Beierle; Xiaojie Ma; Jerry E Stewart; Michael Megison; William G Cance; Elena V Kurenova
Journal:  Mol Carcinog       Date:  2012-10-12       Impact factor: 4.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.